Vor to Participate in the JMP Securities Hematology and Oncology Summit

NEXT STORY
TRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China
PREV STORY
Skylight Health Group to Present at The Benchmark Company’s Discovery One on One Virtual Video Investor Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Paratek Pharmaceuticals Announces FDA Approval of NUZYRA® (omadacycline) Oral Only Dosing Regimen for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)

author_avatar
NASDAQ Market News

PIVOTAL TRIAL CONFIRMS LONG-TERM SAFETY AND EFFICACY OF IV IRON DOSING STRATEGY

PIVOTAL TRIAL CONFIRMS LONG-TERM SAFETY AND EFFICACY OF INTRAVENOUS IRON DOSING STRATEGY ALLOWING HIGHER ...

author_avatar
NASDAQ Market News

Genkyotex Reports Clinical Evidence of Anti-fibrotic Activity by GKT831 in Liver Fibrosis Patients

author_avatar
NASDAQ Market News